AIToday
Large Language ModelsAI Safety & AlignmentHacker NewsPublished: Aug 7, 2026, 06:00 JST

AI designs working viruses from scratch; researchers flag biosecurity risks

AI designs working viruses from scratch; researchers flag biosecurity risks

3 Key Points

  1. What happened

    Researchers led by Samuel King used AI language models (called Evo) combined with computational biology to design complete bacteriophage genomes from scratch, then tested 16 of hundreds of computationally designed candidates in the lab. Some of the engineered phages performed comparably to naturally occurring ones, and notably, some combinations overcame resistance in two strains of E. coli that resisted ΦX174-like phages.

  2. Why it matters

    This marks a shift toward AI systems capable of engineering entire biological systems rather than individual genes—a capability that could enable more durable phage-based therapies for bacterial infections. However, the same capability introduces serious biosafety and biosecurity concerns, since the ability to design and synthesize functional AI-generated genomes means potentially harmful viral sequences could be engineered.

  3. What to watch

    King et al. and commentators Inglesby and Hanke emphasize that groups conducting future whole-genome design work should consult safety and security professionals throughout the project lifecycle. The researchers propose that existing safety frameworks can be adapted to generative genomics, and that model-level protections—such as excluding sensitive viral sequences from training data—may provide an additional layer of risk mitigation.

Not sure about something? Ask the AI

Questions and answers are published on this page.

Summaries like this, in your inbox every morning.

Context & Analysis

The work by Samuel King and colleagues represents a significant leap in computational biology: the ability to design complete, functional genomic systems from first principles rather than tweaking existing sequences. Previous advances in DNA sequencing and synthesis made it increasingly possible to read and write entire genomes, but designing a functional genome from scratch remained extraordinarily difficult because genes, regulatory sequences, and other elements interact in highly complex ways. King's team bridged this gap by combining Evo genomic language models (including Evo 1), computational biology, and experimental screening—a methodological integration that allowed them to generate and test hundreds of candidate designs efficiently.

The practical demonstration using bacteriophages—viruses that infect bacteria—grounds the work in a domain with immediate therapeutic relevance. Phage therapy has long been considered a potential tool against antibiotic-resistant bacteria, but designing phages that remain effective as bacteria evolve resistance has been a persistent challenge. The finding that some engineered phage combinations could overcome resistance in E. coli strains that had become resistant to ΦX174-like phages suggests this AI-guided approach could unlock a new generation of durable therapeutics.

At the same time, commentators Thomas Inglesby and Moritz Hanke note that the capability to design and synthesize functional AI-generated viral genomes introduces a novel and serious risk: the same generative capacity that enables therapeutic design could potentially be misused to engineer harmful pathogens. The researchers acknowledge this explicitly and call for robust oversight, including consulting safety and security professionals throughout the design process and adapting existing safety frameworks to this new domain. Their framing—that the question is no longer whether generative viral genome design will exist, but whether society can build oversight that allows its benefits while preventing harm—reflects recognition that the technology is now inevitable and that governance structures must evolve alongside it.

FAQ
How many of the designed bacteriophages actually worked?
The researchers computationally designed hundreds of candidate genomes and experimentally identified 16 functional phages, whose genetic sequences and structures differed substantially from one another.
What makes these engineered phages potentially useful as treatments?
Some of the engineered phages performed comparably to naturally occurring relatives, and notably, some combinations of the new phages overcame resistance in two strains of E. coli that resisted ΦX174-like phages, suggesting they could enable more durable phage-based therapies for bacterial infections.
What safeguards do the researchers propose?
King et al. argue that existing safety frameworks can be adapted to generative genomics, and that model-level protections such as excluding sensitive viral sequences from training data may provide an additional layer of risk mitigation. They also call for groups conducting future whole-genome design work to consult both safety and security professionals throughout the project lifecycle.

Get the latest Large Language Models news every morning

For example, today's edition would include:

  • Nvidia unveils security platform to stop rogue AI agentsTop Companies AI · 2h ago
  • Home Depot (NYSE:HD) rolls out AI assistant for shoppersTop Companies AI · 2h ago
  • AMD to buy Fei-Fei Li's World Labs for $8.2 billionTop Companies AI · 2h ago

AI-summarized, only the topics you pick: one digest a day via Email, LINE, or Slack.

Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.

Questions and answers are published on this page.

Related Articles

Next articleGitHub Copilot app adds slash commands for faster workflows